Reference tables
What the checker uses to cross-reference conditions, lab values and combinations of medications, and where its drug data comes from.
Data sources
| Source | Used for | Last updated |
|---|---|---|
| RxNorm (NLM) | Drug names, strengths, identifiers (RxCUI) and active ingredients | Checking… |
| RxClass / MED-RT (NLM) | Drug classes, and the diseases a drug is contraindicated with or may treat | Checking… |
| DailyMed (NLM) | The FDA-approved label of each drug: boxed warning, contraindications, drug interactions, warnings, laboratory tests | Checking… |
| Clinical Table Search Service (NLM) | Type-ahead search of drug names and ICD-10-CM condition codes | Checking… |
| Dietary Supplement Label Database (NIH) | Supplement products and their ingredients | Checking… |
| MedlinePlus (NLM) | Plain-language pages linked from each medication | Live link — nothing is stored |
Last updated shows the publisher's own data date where the service reports one, and below it when this site last fetched from that source. Fetched data is reused for up to 30 days (searches: 7 days) before it is requested again.
The National Library of Medicine retired its drug-interaction lookup API in January 2024; interaction findings on this site are therefore drawn from the label text itself. This product uses publicly available data courtesy of the U.S. National Library of Medicine, National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
ICD-10 prefix lookup table (122 rows)
A condition's ICD-10 code is matched to the longest prefix in this table — E87.5 wins over E87 — and the keywords of that row are what the check searches for in each drug's MED-RT contraindications and in the Contraindications and Warnings sections of its label.
| Prefix | Condition group | Category | Keywords searched |
|---|---|---|---|
| B18 | Chronic viral hepatitis | Infectious | hepatitis, hepatic impairment, liver disease, hepatic insufficiency, hepatotoxicity |
| B20 | HIV disease | Infectious | hiv, immunocompromised, immunosuppress |
| C50 | Breast cancer | Oncology | breast cancer, carcinoma of the breast, estrogen-dependent, hormone-sensitive |
| C61 | Prostate cancer | Oncology | prostate cancer, carcinoma of the prostate, androgen-dependent |
| D50 | Iron deficiency anemia | Blood | anemia, iron deficiency |
| D55 | G6PD deficiency and other enzyme anemias | Blood | g6pd, glucose-6-phosphate dehydrogenase, hemolytic anemia, hemolysis |
| D57 | Sickle-cell disorders | Blood | sickle cell, hemolytic anemia |
| D64 | Anemia | Blood | anemia |
| D65 | Disseminated intravascular coagulation | Blood | coagulopathy, bleeding, hemorrhag |
| D66 | Hemophilia A | Blood | hemophilia, bleeding disorder, bleeding, hemorrhag |
| D68 | Coagulation defects | Blood | coagulopathy, bleeding disorder, bleeding, hemorrhag, thrombophilia |
| D69 | Thrombocytopenia and purpura | Blood | thrombocytopenia, low platelet, bleeding, hemorrhag |
| D70 | Neutropenia | Blood | neutropenia, agranulocytosis, leukopenia |
| E03 | Hypothyroidism | Endocrine | hypothyroid, thyroid |
| E05 | Hyperthyroidism | Endocrine | hyperthyroid, thyrotoxicosis, thyroid |
| E10 | Type 1 diabetes mellitus | Endocrine | diabetes, diabetic, hyperglycemia, hypoglycemia, ketoacidosis, glucose control |
| E11 | Type 2 diabetes mellitus | Endocrine | diabetes, diabetic, hyperglycemia, hypoglycemia, glucose control |
| E13 | Other specified diabetes mellitus | Endocrine | diabetes, diabetic, hyperglycemia, hypoglycemia |
| E21 | Hyperparathyroidism | Endocrine | hyperparathyroid, hypercalcemia |
| E24 | Cushing syndrome | Endocrine | cushing, hypercortisolism |
| E27 | Adrenal insufficiency and other adrenal disorders | Endocrine | adrenal insufficiency, adrenal suppression, addison |
| E55 | Vitamin D deficiency | Nutritional | vitamin d |
| E66 | Overweight and obesity | Nutritional | obesity, obese |
| E78 | Disorders of lipoprotein metabolism (high cholesterol) | Metabolic | hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, dyslipidemia |
| E83 | Disorders of mineral metabolism | Metabolic | hypercalcemia, hypocalcemia, hypomagnesemia, hemochromatosis, iron overload |
| E86 | Volume depletion (dehydration) | Metabolic | dehydration, volume depletion, hypovolemia |
| E87 | Fluid and electrolyte disorders | Metabolic | electrolyte, hyponatremia, hypokalemia, hyperkalemia |
| E87.1 | Hyponatremia | Metabolic | hyponatremia, low sodium, siadh |
| E87.5 | Hyperkalemia | Metabolic | hyperkalemia, elevated potassium, high potassium |
| E87.6 | Hypokalemia | Metabolic | hypokalemia, low potassium, potassium depletion |
| F03 | Dementia | Mental health | dementia, cognitive impairment, elderly patients with dementia |
| F10 | Alcohol-related disorders | Mental health | alcohol, alcoholism |
| F11 | Opioid-related disorders | Mental health | opioid, substance abuse, drug abuse, addiction |
| F17 | Nicotine dependence (smoking) | Mental health | smok, nicotine, tobacco |
| F20 | Schizophrenia | Mental health | schizophrenia, psychosis, psychotic |
| F31 | Bipolar disorder | Mental health | bipolar, mania, manic, hypomania |
| F32 | Depression (single episode) | Mental health | depression, depressive, suicid |
| F33 | Depression (recurrent) | Mental health | depression, depressive, suicid |
| F41 | Anxiety disorders | Mental health | anxiety, panic |
| F50 | Eating disorders | Mental health | anorexia, bulimia, eating disorder |
| F90 | Attention-deficit hyperactivity disorder | Mental health | adhd, attention deficit |
| G20 | Parkinson disease | Neurological | parkinson, extrapyramidal |
| G30 | Alzheimer disease | Neurological | alzheimer, dementia, cognitive impairment |
| G35 | Multiple sclerosis | Neurological | multiple sclerosis |
| G40 | Epilepsy and recurrent seizures | Neurological | seizure, epilep, convuls |
| G43 | Migraine | Neurological | migraine |
| G45 | Transient ischemic attack | Neurological | transient ischemic, cerebrovascular, stroke |
| G47 | Sleep disorders | Neurological | sleep apnea, respiratory depression, insomnia |
| G47.3 | Sleep apnea | Neurological | sleep apnea, respiratory depression, sleep-related breathing |
| G62 | Polyneuropathy | Neurological | neuropathy, peripheral neuropathy |
| G70 | Myasthenia gravis | Neurological | myasthenia gravis, neuromuscular |
| H40 | Glaucoma | Eye | glaucoma, angle-closure, narrow-angle, intraocular pressure |
| I10 | Essential (primary) hypertension | Cardiovascular | hypertension, hypertensive, blood pressure |
| I11 | Hypertensive heart disease | Cardiovascular | hypertension, hypertensive, heart failure, blood pressure |
| I12 | Hypertensive chronic kidney disease | Cardiovascular | hypertension, renal impairment, renal insufficiency, kidney disease, renal failure |
| I20 | Angina pectoris | Cardiovascular | angina, ischemic heart disease, coronary artery disease |
| I21 | Acute myocardial infarction | Cardiovascular | myocardial infarction, ischemic heart disease, coronary artery disease, cardiovascular thrombotic |
| I25 | Chronic ischemic heart disease | Cardiovascular | coronary artery disease, ischemic heart disease, myocardial infarction, angina, cardiovascular disease |
| I26 | Pulmonary embolism | Cardiovascular | pulmonary embolism, thromboembol, thrombosis |
| I27 | Pulmonary hypertension | Cardiovascular | pulmonary hypertension |
| I42 | Cardiomyopathy | Cardiovascular | cardiomyopathy, heart failure, left ventricular dysfunction |
| I44 | Atrioventricular and left bundle-branch block | Cardiovascular | heart block, av block, atrioventricular block, bradycardia, conduction |
| I45 | Other conduction disorders | Cardiovascular | heart block, conduction, bradycardia, qt prolongation |
| I45.81 | Long QT syndrome | Cardiovascular | qt prolongation, long qt, qt interval, torsade |
| I47 | Paroxysmal tachycardia | Cardiovascular | tachycardia, arrhythmia |
| I48 | Atrial fibrillation and flutter | Cardiovascular | atrial fibrillation, atrial flutter, arrhythmia |
| I49 | Other cardiac arrhythmias | Cardiovascular | arrhythmia, bradycardia, sick sinus, qt prolongation |
| I50 | Heart failure | Cardiovascular | heart failure, cardiac failure, congestive, left ventricular dysfunction, fluid retention, edema |
| I63 | Cerebral infarction (stroke) | Cardiovascular | stroke, cerebrovascular, cerebral infarction |
| I70 | Atherosclerosis | Cardiovascular | atherosclerosis, peripheral arterial, cardiovascular disease |
| I73 | Peripheral vascular disease | Cardiovascular | peripheral vascular, raynaud, peripheral arterial |
| I82 | Venous embolism and thrombosis | Cardiovascular | thrombosis, thromboembol, deep vein |
| I95 | Hypotension | Cardiovascular | hypotension, orthostatic, syncope |
| J44 | Chronic obstructive pulmonary disease | Respiratory | copd, chronic obstructive, bronchospasm, respiratory depression |
| J45 | Asthma | Respiratory | asthma, bronchospasm, bronchospastic |
| J84 | Interstitial lung disease | Respiratory | interstitial lung, pulmonary fibrosis, pulmonary toxicity, pneumonitis |
| K21 | Gastro-esophageal reflux disease | Digestive | reflux, esophagitis, gerd |
| K25 | Gastric ulcer | Digestive | peptic ulcer, gastric ulcer, gastrointestinal bleeding, gi bleeding, ulceration |
| K26 | Duodenal ulcer | Digestive | peptic ulcer, duodenal ulcer, gastrointestinal bleeding, gi bleeding, ulceration |
| K27 | Peptic ulcer | Digestive | peptic ulcer, gastrointestinal bleeding, gi bleeding, ulceration |
| K50 | Crohn disease | Digestive | crohn, inflammatory bowel |
| K51 | Ulcerative colitis | Digestive | ulcerative colitis, inflammatory bowel |
| K56 | Bowel obstruction and ileus | Digestive | ileus, bowel obstruction, gastrointestinal obstruction |
| K58 | Irritable bowel syndrome | Digestive | irritable bowel |
| K59 | Constipation and other functional bowel disorders | Digestive | constipation, ileus |
| K70 | Alcoholic liver disease | Liver | hepatic impairment, liver disease, hepatic insufficiency, cirrhosis, hepatic failure, hepatotoxicity, alcohol |
| K72 | Hepatic failure | Liver | hepatic impairment, liver disease, hepatic insufficiency, hepatic failure, hepatotoxicity |
| K74 | Fibrosis and cirrhosis of liver | Liver | hepatic impairment, liver disease, hepatic insufficiency, cirrhosis, hepatotoxicity |
| K75 | Other inflammatory liver diseases | Liver | hepatic impairment, liver disease, hepatitis, hepatotoxicity |
| K76 | Other diseases of liver (including fatty liver) | Liver | hepatic impairment, liver disease, hepatic insufficiency, hepatotoxicity |
| K80 | Gallstones | Digestive | gallbladder, cholelithiasis, gallstone |
| K85 | Acute pancreatitis | Digestive | pancreatitis |
| K86 | Other diseases of pancreas | Digestive | pancreatitis |
| K92 | Gastrointestinal hemorrhage and other digestive disease | Digestive | gastrointestinal bleeding, gi bleeding, hemorrhag, bleeding |
| L40 | Psoriasis | Skin | psoriasis |
| M05 | Rheumatoid arthritis with rheumatoid factor | Musculoskeletal | rheumatoid arthritis |
| M06 | Other rheumatoid arthritis | Musculoskeletal | rheumatoid arthritis |
| M10 | Gout | Musculoskeletal | gout, hyperuricemia, uric acid |
| M1A | Chronic gout | Musculoskeletal | gout, hyperuricemia, uric acid |
| M32 | Systemic lupus erythematosus | Musculoskeletal | lupus |
| M80 | Osteoporosis with fracture | Musculoskeletal | osteoporosis, bone loss, fracture, bone mineral density |
| M81 | Osteoporosis | Musculoskeletal | osteoporosis, bone loss, fracture, bone mineral density |
| N17 | Acute kidney failure | Kidney | renal impairment, renal insufficiency, renal failure, kidney injury, acute kidney, nephrotoxicity, renal function |
| N18 | Chronic kidney disease | Kidney | renal impairment, renal insufficiency, kidney disease, renal failure, kidney failure, renal disease, renal function, creatinine clearance |
| N19 | Kidney failure (unspecified) | Kidney | renal impairment, renal insufficiency, renal failure, kidney failure, renal function |
| N20 | Kidney and ureter stones | Kidney | nephrolithiasis, kidney stone, renal calculi, urolithiasis |
| N39 | Urinary tract infection and other urinary disorders | Kidney | urinary tract infection, urinary retention |
| N40 | Benign prostatic hyperplasia | Genitourinary | prostatic hyperplasia, prostatic hypertrophy, urinary retention, bladder outlet obstruction, bladder neck obstruction |
| O | Pregnancy and childbirth | Pregnancy | pregnan, fetal, fetus, teratogen, embryo |
| R33 | Urinary retention | Genitourinary | urinary retention, bladder outlet obstruction |
| R56 | Convulsions (seizures) | Neurological | seizure, convuls, epilep |
| Z33 | Pregnant state | Pregnancy | pregnan, fetal, fetus, teratogen, embryo |
| Z34 | Supervision of normal pregnancy | Pregnancy | pregnan, fetal, fetus, teratogen, embryo |
| Z39.1 | Lactating mother (breastfeeding) | Pregnancy | lactation, breastfeeding, breast-feeding, nursing mother, nursing infant, human milk |
| Z88.0 | Allergy status to penicillin | Allergy | penicillin, beta-lactam, cephalosporin |
| Z88.1 | Allergy status to other antibiotics | Allergy | hypersensitivity |
| Z88.2 | Allergy status to sulfonamides | Allergy | sulfonamide, sulfa |
| Z88.5 | Allergy status to narcotic agents | Allergy | opioid, narcotic |
| Z88.6 | Allergy status to analgesic agents | Allergy | aspirin, nsaid, nonsteroidal, salicylate |
| Z94.0 | Kidney transplant status | Transplant | transplant, renal impairment, immunosuppress |
| Z94.4 | Liver transplant status | Transplant | transplant, hepatic impairment, immunosuppress |
| Z99.2 | Dependence on renal dialysis | Kidney | dialysis, renal impairment, renal failure, end-stage renal, kidney failure |
Three-way combination rules (8 rules)
Some risks build up across three or more medications and are not visible in any single pair, so no one label describes them. Each medication's ingredients are sorted into the groups below — by their ATC drug class from RxClass, or by name — and a rule is met when the list has enough different ingredients in its groups. Every rule cites the source it rests on.
| Rule | Needs | Grade | Why, and the source |
|---|---|---|---|
| "Triple whammy" (kidney injury) | ACE inhibitor / ARB / renin inhibitor + Diuretic + NSAID (not aspirin) | Use caution | Taking an ACE inhibitor or ARB, a diuretic and an NSAID together raises the risk of acute kidney injury, most in the first month after the third drug is added.
Lapi F, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury. BMJ 2013;346:e8525. |
| Opioid with two or more sedatives | Opioid + 2 × Sedative or other CNS depressant | Use caution | An opioid combined with other drugs that slow the brain (benzodiazepines, sleep medicines, gabapentin or pregabalin, muscle relaxants, sedating antihistamines) adds to the risk of dangerous sleepiness and slowed breathing; each additional sedative raises it further.
FDA Drug Safety Communications: opioids with benzodiazepines and other CNS depressants (Aug 31, 2016); gabapentin and pregabalin with CNS depressants (Dec 19, 2019). |
| Three or more drugs that raise bleeding risk | 3 × Raises bleeding risk | Use caution | Anticoagulants, antiplatelets (including aspirin), NSAIDs and SSRI or SNRI antidepressants each raise the risk of bleeding, and the risk adds up with each one taken.
Each drug's FDA label (Drug Interactions / Warnings: concomitant use of drugs that affect hemostasis); de Abajo FJ. Drugs Aging 2011;28:861-875. |
| Three or more drugs that raise potassium | 3 × Raises potassium | Use caution | ACE inhibitors and ARBs, potassium-sparing diuretics, potassium supplements and trimethoprim each raise blood potassium; together they can cause dangerous hyperkalemia. Potassium is usually checked with blood tests.
Each drug's FDA label (Warnings: hyperkalemia); Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther 2012;30:e156-166. |
| Three or more serotonergic drugs | 3 × Serotonergic | Use caution | Each serotonergic drug adds to the risk of serotonin syndrome (agitation, sweating, fast heart rate, tremor or muscle twitching, fever).
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-1120; FDA Drug Safety Communication on opioids and serotonin syndrome (Mar 22, 2016). |
| Three or more drugs that prolong the QT interval | 3 × Known risk of QT prolongation | Use caution | Drugs that prolong the QT interval add to each other's effect on heart rhythm, raising the risk of torsades de pointes, a dangerous arrhythmia; an ECG may be advised.
Drew BJ, et al. Prevention of torsade de pointes in hospital settings: AHA/ACCF scientific statement. Circulation 2010;121:1047-1060; CredibleMeds QTdrugs list (Known Risk of TdP). |
| Three or more strongly anticholinergic drugs | 3 × Strongly anticholinergic | Use caution | Anticholinergic effects add up: confusion, memory problems, constipation, urinary retention and falls, especially in older adults.
American Geriatrics Society 2023 Updated AGS Beers Criteria. J Am Geriatr Soc 2023;71:2052-2081 (avoid combining anticholinergic drugs in older adults). |
| Three or more CNS-active drugs | 3 × CNS-active (falls risk) | Monitor | For older adults, taking three or more drugs that act on the brain (antidepressants, antiepileptics, antipsychotics, benzodiazepines, sleep medicines, opioids, muscle relaxants) raises the risk of falls and fractures.
American Geriatrics Society 2023 Updated AGS Beers Criteria. J Am Geriatr Soc 2023;71:2052-2081 (any combination of three or more CNS-active drugs). |
Groups (11)
| Group | ATC classes | Named drugs and supplements |
|---|---|---|
| ACE inhibitor / ARB / renin inhibitor Angiotensin system blockers |
C09 | sacubitril |
| Diuretic Loop / thiazide / potassium-sparing diuretics |
C03 | — |
| NSAID (not aspirin) Aspirin is classed as an antiplatelet/salicylate (B01AC / N02BA) and is not counted here |
M01A | — Not counted: aspirin |
| Opioid |
N02A, R05DA, N07BC | — Not counted: naloxone, naltrexone, methylnaltrexone |
| Sedative or other CNS depressant Benzodiazepines / Z-drugs / barbiturates / gabapentinoids / muscle relaxants / sedating antihistamines and antipsychotics |
N05BA, N05CD, N05CF, N05CA, N03AA | gabapentin, pregabalin, carisoprodol, cyclobenzaprine, methocarbamol, metaxalone, tizanidine, baclofen, hydroxyzine, promethazine, diphenhydramine, doxylamine, quetiapine, olanzapine, trazodone, mirtazapine |
| Raises bleeding risk Anticoagulants / antiplatelets / NSAIDs / SSRIs and SNRIs / some supplements |
B01AA, B01AB, B01AE, B01AF, B01AC, N02BA, M01A, N06AB | venlafaxine, desvenlafaxine, duloxetine, levomilnacipran, milnacipran, fish oil, omega-3, ginkgo |
| Raises potassium ACE inhibitors / ARBs / potassium-sparing diuretics / potassium supplements / trimethoprim |
C09, C03DA, C03DB, A12BA | trimethoprim, drospirenone, potassium chloride, potassium citrate, potassium gluconate, heparin, amiloride, triamterene |
| Serotonergic SSRIs / SNRIs / MAOIs / triptans / serotonergic opioids and others |
N06AB, N06AF, N06AG, N02CC | venlafaxine, desvenlafaxine, duloxetine, levomilnacipran, milnacipran, vilazodone, vortioxetine, trazodone, nefazodone, mirtazapine, clomipramine, imipramine, amitriptyline, tramadol, tapentadol, meperidine, methadone, fentanyl, dextromethorphan, linezolid, methylene blue, lithium, buspirone, cyclobenzaprine, st. john's wort, st john's wort, tryptophan |
| Known risk of QT prolongation Drugs with a known risk of torsades de pointes; check the current CredibleMeds list |
— | amiodarone, sotalol, dofetilide, dronedarone, quinidine, disopyramide, procainamide, ibutilide, haloperidol, chlorpromazine, thioridazine, pimozide, droperidol, citalopram, escitalopram, methadone, ondansetron, azithromycin, clarithromycin, erythromycin, levofloxacin, moxifloxacin, ciprofloxacin, fluconazole, hydroxychloroquine, chloroquine, donepezil, cilostazol, pentamidine, anagrelide, arsenic trioxide, vandetanib |
| Strongly anticholinergic Anticholinergic Cognitive Burden score 3 |
— | amitriptyline, amoxapine, atropine, benztropine, chlorpheniramine, chlorpromazine, clemastine, clomipramine, clozapine, darifenacin, desipramine, dicyclomine, diphenhydramine, doxepin, doxylamine, fesoterodine, flavoxate, hydroxyzine, hyoscyamine, imipramine, meclizine, nortriptyline, olanzapine, orphenadrine, oxybutynin, paroxetine, perphenazine, promethazine, protriptyline, quetiapine, scopolamine, solifenacin, thioridazine, tolterodine, trihexyphenidyl, trimipramine, trospium |
| CNS-active (falls risk) Antiepileptics / antipsychotics / antidepressants / benzodiazepines / Z-drugs / opioids / skeletal muscle relaxants |
N03, N05A, N06A, N05BA, N05CD, N05CF, N02A, M03B | gabapentin, pregabalin |
Lab reference ranges (39 tests)
Typical adult ranges, used only to decide whether a result you entered is high or low. Laboratories differ; the range on your own report takes precedence. When a result is out of range, the terms in the last two columns are searched for in each label.
| Test | LOINC | Unit | Usual range | Searched when high | Searched when low |
|---|---|---|---|---|---|
| Sodium | 2951-2 | mmol/L | 135 – 145 | hypernatremia | hyponatremia, low sodium, siadh |
| Potassium | 2823-3 | mmol/L | 3.5 – 5.1 | hyperkalemia, elevated potassium, increases in serum potassium, increase in serum potassium, potassium-sparing | hypokalemia, potassium depletion, potassium loss, low potassium |
| Chloride | 2075-0 | mmol/L | 98 – 107 | hyperchloremi | hypochloremi |
| Carbon dioxide (bicarbonate) | 2028-9 | mmol/L | 22 – 29 | metabolic alkalosis | metabolic acidosis, lactic acidosis |
| Urea nitrogen (BUN) | 3094-0 | mg/dL | 7 – 20 | increases in bun, elevated bun, azotemia, renal impairment, renal function | |
| Creatinine | 2160-0 | mg/dL | 0.6 – 1.3 | increases in serum creatinine, elevated creatinine, renal impairment, renal insufficiency, nephrotoxicity, renal failure, creatinine clearance | |
| eGFR (estimated kidney function) | 62238-1 | mL/min/1.73m2 | 60 or more | renal impairment, renal insufficiency, reduced renal function, creatinine clearance, egfr, renal failure, dose adjustment | |
| Glucose (fasting) | 2345-7 | mg/dL | 70 – 99 | hyperglycemia, glucose intolerance, loss of glycemic control, increased blood glucose | hypoglycemia |
| Hemoglobin A1c | 4548-4 | % | 4 – 5.6 | hyperglycemia, loss of glycemic control, increased blood glucose, glucose intolerance | |
| Calcium | 17861-6 | mg/dL | 8.6 – 10.2 | hypercalcemia | hypocalcemia |
| Magnesium | 19123-9 | mg/dL | 1.7 – 2.2 | hypermagnesemia | hypomagnesemia |
| Phosphate | 2777-1 | mg/dL | 2.5 – 4.5 | hyperphosphatemia | hypophosphatemia |
| ALT (liver enzyme) | 1742-6 | U/L | 7 – 55 | elevated liver enzymes, transaminase elevation, elevations in serum transaminases, hepatotoxicity, liver injury, hepatic injury, alt elevation, hepatitis | |
| AST (liver enzyme) | 1920-8 | U/L | 8 – 48 | elevated liver enzymes, transaminase elevation, elevations in serum transaminases, hepatotoxicity, liver injury, hepatic injury, hepatitis | |
| Alkaline phosphatase | 6768-6 | U/L | 40 – 129 | cholestasis, cholestatic, hepatotoxicity | |
| Bilirubin (total) | 1975-2 | mg/dL | 0.1 – 1.2 | hyperbilirubinemia, jaundice, cholestasis, hepatotoxicity | |
| Albumin | 1751-7 | g/dL | 3.5 – 5 | hypoalbuminemia, protein binding | |
| Cholesterol (total) | 2093-3 | mg/dL | under 200 | hypercholesterolemia, increases in cholesterol, lipid elevations, hyperlipidemia | |
| LDL cholesterol | 13457-7 | mg/dL | under 100 | increases in ldl, hypercholesterolemia, lipid elevations | |
| HDL cholesterol | 2085-9 | mg/dL | 40 or more | decreases in hdl, decreased hdl | |
| Triglycerides | 2571-8 | mg/dL | under 150 | hypertriglyceridemia, increases in triglycerides, elevated triglycerides | |
| TSH (thyroid stimulating hormone) | 3016-3 | mIU/L | 0.4 – 4 | hypothyroid | hyperthyroid, thyrotoxicosis |
| Free T4 | 3024-7 | ng/dL | 0.8 – 1.8 | hyperthyroid, thyrotoxicosis | hypothyroid |
| INR | 6301-6 | ratio | 0.8 – 1.1 | increased inr, increase in inr, elevated inr, prolonged prothrombin, bleeding, hemorrhag, increase the anticoagulant, potentiate the anticoagulant, effect of coumarin, effect of warfarin | decreased inr, decrease in inr, reduce the anticoagulant, decreased anticoagulant |
| Prothrombin time | 5902-2 | seconds | 11 – 13.5 | prolonged prothrombin, bleeding, hemorrhag | |
| Hemoglobin | 718-7 | g/dL | 12 – 17.5 | polycythemia, erythrocytosis | anemia, decreases in hemoglobin, bleeding, hemorrhag, hemolysis |
| Hematocrit | 4544-3 | % | 36 – 50 | polycythemia, erythrocytosis | anemia, decreases in hematocrit, bleeding, hemorrhag |
| White blood cell count | 6690-2 | 10^3/uL | 4 – 11 | leukocytosis | leukopenia, neutropenia, agranulocytosis, myelosuppression, bone marrow suppression |
| Neutrophils (absolute) | 751-8 | 10^3/uL | 1.5 – 8 | neutropenia, agranulocytosis, myelosuppression, bone marrow suppression | |
| Platelet count | 777-3 | 10^3/uL | 150 – 400 | thrombocytosis | thrombocytopenia, low platelet, bleeding, myelosuppression |
| Uric acid | 3084-1 | mg/dL | 3.5 – 7.2 | hyperuricemia, gout | |
| Creatine kinase (CK) | 2157-6 | U/L | 30 – 200 | myopathy, rhabdomyolysis, elevated creatine kinase, cpk elevation | |
| Vitamin D (25-hydroxy) | 1989-3 | ng/mL | 30 – 100 | hypercalcemia, vitamin d toxicity | vitamin d deficiency |
| Vitamin B12 | 2132-9 | pg/mL | 200 – 900 | vitamin b12 deficiency, b12 deficiency, decrease in vitamin b12 | |
| Ferritin | 2276-4 | ng/mL | 20 – 300 | iron overload | iron deficiency |
| BNP | 30934-4 | pg/mL | under 100 | heart failure, fluid retention, edema | |
| Lithium level | 14334-7 | mmol/L | 0.6 – 1.2 | lithium toxicity, increase serum lithium, increased lithium, elevated lithium, reduce renal clearance of lithium | decrease serum lithium, decreased lithium |
| Digoxin level | 10535-3 | ng/mL | 0.5 – 2 | digoxin toxicity, increase serum digoxin, increased digoxin, elevated digoxin | decrease serum digoxin, decreased digoxin |
| PSA (prostate specific antigen) | 2857-1 | ng/mL | under 4 | prostate cancer | decrease in psa, reduces serum psa, psa levels |